C of A [GxP / QC / QA]

posted by Dr_Dan  – Germany, 2011-02-17 11:26 (5602 d 03:35 ago) – Posting: # 6640
Views: 9,000

Dear VM
usually you perform a clinical study in order to make a statement about the efficacy, the safety, the bioavailability etc. of the tested product. For this you definitely need to know the quality of the product. In your case you just need plasma samples in order to develop a bioanalytical method and there is no gain in knowledge about the drug. That's why I think that a CoA is not of that importance. Nevertheless it is always better to proof the assay content of the drug and if you use the data to describe the pharmacokinetics of the reference product in order to plan a BE study it would be better to have a CoA.
I hope this helps.
Kind regards
Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
147 visitors (0 registered, 147 guests [including 36 identified bots]).
Forum time: 16:02 CEST (Europe/Vienna)

I have finally come to the konklusion
that a good reliable set ov bowels
iz worth more to a man
than enny quantity of brains.    Josh Billings

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5